HER-2 Targeted Drugs for Breast Cancer Market Key Drivers and Forecast 2025-2032
HER-2 Targeted Drugs for Breast Cancer Market Trends And Drivers The HER-2 targeted drugs for breast cancer market size was valued at USD 15.8 billion in 2022 and is projected to reach USD 30.3 billion by 2030, growing at a CAGR of 8.9% from 2024 to 2030. The demand for HER-2 targeted therapies has significantly […]
Continue Reading